136 related articles for article (PubMed ID: 7591186)
21. CYP1A1 gene polymorphism and polycystic ovary syndrome.
Esinler I; Aktas D; Otegen U; Alikasifoglu M; Yarali H; Tuncbilek E
Reprod Biomed Online; 2008 Mar; 16(3):356-60. PubMed ID: 18339256
[TBL] [Abstract][Full Text] [Related]
22. Genetic polymorphisms of drug-metabolizing enzymes and lung cancer susceptibility.
Kawajiri K; Watanabe J; Eguchi H; Hayashi S
Pharmacogenetics; 1995; 5 Spec No():S70-3. PubMed ID: 7581493
[TBL] [Abstract][Full Text] [Related]
23. The heme-binding region polymorphism of cytochrome P450IA1 (CypIA1), rather than the RsaI polymorphism of IIE1 (CypIIE1), is associated with lung cancer in Rio de Janeiro.
Hamada GS; Sugimura H; Suzuki I; Nagura K; Kiyokawa E; Iwase T; Tanaka M; Takahashi T; Watanabe S; Kino I
Cancer Epidemiol Biomarkers Prev; 1995; 4(1):63-7. PubMed ID: 7534543
[TBL] [Abstract][Full Text] [Related]
24. Validation of PCR-RFLP techniques for the evaluation of codon 72 of p53 and CYP1A1 gene's polymorphisms in relation with ovarian cancer in a Romanian population.
Matei MC; Negură L; Liliac L; Negură A; Azoicăi D
Rom J Morphol Embryol; 2012; 53(1):47-54. PubMed ID: 22395499
[TBL] [Abstract][Full Text] [Related]
25. CYP1A1, CYP2E1 and GSTM1 genetic polymorphisms. The effect of single and combined genotypes on lung cancer susceptibility in Chilean people.
Quiñones L; Lucas D; Godoy J; Cáceres D; Berthou F; Varela N; Lee K; Acevedo C; Martínez L; Aguilera AM; Gil L
Cancer Lett; 2001 Dec; 174(1):35-44. PubMed ID: 11675150
[TBL] [Abstract][Full Text] [Related]
26. CYP1A1 Ile462Val polymorphism contributes to colorectal cancer risk: a meta-analysis.
Jin JQ; Hu YY; Niu YM; Yang GL; Wu YY; Leng WD; Xia LY
World J Gastroenterol; 2011 Jan; 17(2):260-6. PubMed ID: 21246002
[TBL] [Abstract][Full Text] [Related]
27. Association of cigarette smoking and CYP1A1 polymorphisms with adenocarcinoma of the lung by grades of differentiation.
Nakachi K; Hayashi S; Kawajiri K; Imai K
Carcinogenesis; 1995 Sep; 16(9):2209-13. PubMed ID: 7554077
[TBL] [Abstract][Full Text] [Related]
28. CYP1A1 gene polymorphism and risk of endometrial hyperplasia and endometrial carcinoma.
Esinler I; Aktas D; Alikasifoglu M; Tuncbilek E; Ayhan A
Int J Gynecol Cancer; 2006; 16(3):1407-11. PubMed ID: 16803538
[TBL] [Abstract][Full Text] [Related]
29. Human glutathione S-transferase P1 polymorphisms: relationship to lung tissue enzyme activity and population frequency distribution.
Watson MA; Stewart RK; Smith GB; Massey TE; Bell DA
Carcinogenesis; 1998 Feb; 19(2):275-80. PubMed ID: 9498276
[TBL] [Abstract][Full Text] [Related]
30. [Polymorphisms of the CYP1A1 and GSTM1 genes and their combined effects on individual susceptibility to lung cancer in a Chinese population].
Xue K; Xu L; Chen S; Ma G; Wu J
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2001 Apr; 18(2):125-7. PubMed ID: 11295132
[TBL] [Abstract][Full Text] [Related]
31. Polychlorinated biphenyls, cytochrome P4501A1 polymorphism, and postmenopausal breast cancer risk.
Moysich KB; Shields PG; Freudenheim JL; Schisterman EF; Vena JE; Kostyniak P; Greizerstein H; Marshall JR; Graham S; Ambrosone CB
Cancer Epidemiol Biomarkers Prev; 1999 Jan; 8(1):41-4. PubMed ID: 9950238
[TBL] [Abstract][Full Text] [Related]
32. CYP1A1 genetic polymorphisms and in situ colorectal cancer.
Sivaraman L; Leatham MP; Yee J; Wilkens LR; Lau AF; Le Marchand L
Cancer Res; 1994 Jul; 54(14):3692-5. PubMed ID: 7913406
[TBL] [Abstract][Full Text] [Related]
33. Association between polycyclic aromatic hydrocarbon-DNA adduct levels in maternal and newborn white blood cells and glutathione S-transferase P1 and CYP1A1 polymorphisms.
Whyatt RM; Perera FP; Jedrychowski W; Santella RM; Garte S; Bell DA
Cancer Epidemiol Biomarkers Prev; 2000 Feb; 9(2):207-12. PubMed ID: 10698483
[TBL] [Abstract][Full Text] [Related]
34. [Study on the association of cytochrome P450 polymorphisms and the risk of esophageal cancer: a meta-analysis].
Dai LP; Wang YP; Wu XB; Wang KJ; Lv QJ
Zhonghua Liu Xing Bing Xue Za Zhi; 2009 Nov; 30(11):1198-202. PubMed ID: 20193595
[TBL] [Abstract][Full Text] [Related]
35. Effects of cytochrome P450 1A1 and uridine-diphosphate-glucuronosyltransferase 1A1 allelic polymorphisms on the risk of development and the prognosis of head and neck cancers.
Szanyi I; Ráth G; Móricz P; Somogyvári K; Révész P; Gerlinger I; Orsós Z; Ember I; Kiss I
Eur J Cancer Prev; 2012 Nov; 21(6):560-8. PubMed ID: 22273851
[TBL] [Abstract][Full Text] [Related]
36. The effect of CYP1A1, GSTT1 and GSTM1 polymorphisms on the risk of lung cancer: a case-control study.
Atinkaya C; Taspinar M; Sakiragaoglu O; Oz G; Yazici U; Oztuna D; Tastepe I; Sunguroglu A
Hum Exp Toxicol; 2012 Oct; 31(10):1074-80. PubMed ID: 22893352
[TBL] [Abstract][Full Text] [Related]
37. Polymorphisms in CYP1A1 and smoking: no association with breast cancer risk.
Basham VM; Pharoah PD; Healey CS; Luben RN; Day NE; Easton DF; Ponder BA; Dunning AM
Carcinogenesis; 2001 Nov; 22(11):1797-800. PubMed ID: 11698341
[TBL] [Abstract][Full Text] [Related]
38. CYP1A1 Ile462Val polymorphism contributes to lung cancer susceptibility among lung squamous carcinoma and smokers: a meta-analysis.
Ji YN; Wang Q; Suo LJ
PLoS One; 2012; 7(8):e43397. PubMed ID: 22952673
[TBL] [Abstract][Full Text] [Related]
39. CYP1A1 Ile462Val polymorphism as a risk factor in cervical cancer development in the Polish population.
Roszak A; Lianeri M; Sowińska A; Jagodziński PP
Mol Diagn Ther; 2014 Aug; 18(4):445-50. PubMed ID: 24626963
[TBL] [Abstract][Full Text] [Related]
40. Risk for K-ras gene mutations in smoking-induced lung cancer is associated with cytochrome P4501A1 and glutathione S-transferase micro1 polymorphisms.
Noda N; Matsuzoe D; Konno T; Kawahara K; Yamashita Y; Shirakusa T
Oncol Rep; 2004 Oct; 12(4):773-9. PubMed ID: 15375499
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
